The best and brightest of British Columbia’s emerging life sciences sector will be on display next week, as investors from around the world gather virtually to hear their pitches. The two-day event, organized by non-profit LifeSciences BC, will feature 33 up-and-coming companies, with up to 70 investors dialing in from Asia, Europe and the U.S. While the summit is an…
Read More
Two Japanese institutions, a Korean biotechnology start-up, and a Canadian biotech company have entered into a research collaboration to identify biomarkers unique to lung cancer cells suitable for targeted therapeutics. As of October 13, 2020, Japan’s largest comprehensive research organization, RIKEN; Keio University of Japan; iProgen Biotech Inc. of Canada, and iPrime Therapeutics Co., Ltd of Korea agreed to the…
Read More

October 2020 Award Winners

Ariana Cahn (pictured), an MSc student under the supervision of Drs. Lakshmi Yatham and Trisha Chakrabarty, has received a Djavad Mowafaghian Centre for Brain Health Endowment Award for transformational activity in mental health. Find out which other Vancouver researchers won grants, awards, fellowships and scholarships in our October 2020 award summary!
Read More
LifeSciences BC, a non-profit, industry association which supports the life sciences sector of British Columbia, and Lumira Ventures, a leading North American healthcare venture capital firm, will host the 5th Annual LifeSciences BC’s Investor Summit in Vancouver, B.C., virtually on November 2nd and 3rd, 2020. With keynotes given by Mr. Daniel Hétu, Managing Director of Lumira Ventures and Mr. Peter Greenleaf, CEO Aurinia Pharmaceuticals, the…
Read More
Both higher plants and mammals rely on nucleotide-binding leucine-rich repeat (NLR) immune receptors to detect pathogens and initiate immunity. Upon effector recognition, plant NLRs oligomerize for defense activation, the mechanism of which is poorly understood. Their findings indicate links between plant NLRs and an SCF complex that may enable ubiquitination and degradation of unknown downstream components to activate defense.
Read More

Novel Computational Tool Accurately and Quickly Detects Circular RNA

Scientific research into the double- and single-helix linear structures of DNA and RNA has revealed a mystery in the form of circular RNA (circRNA). As interest grows in these strands of RNA that are continuous loop shapes, a new computational tool called CircMiner, developed by Vancouver Coastal Health Research Institute scientist Dr. Faraz Hach and his team at the Vancouver…
Read More
Genome British Columbia (Genome BC) is thrilled to congratulate two BC-led teams for their projects designed to harness the power and potential of bio-innovation to create healthier, more sustainable and prosperous communities. The two projects, jointly valued at over $10 million, bring together the best of Canadian applied science and commercialization. The first project, CLEan plAnt extractioN SEquencing Diagnostics (CLEANSED) for…
Read More
Symvivo Corporation today announced that it is receiving advisory services and funding of up to $2.8 million from the National Research Council Industrial Research Assistance Program (NRC IRAP) to support the clinical advancement of bacTRL-Spike™, the company’s oral, room temperature-stable DNA vaccine candidate for the prevention of COVID-19. The funding follows a notification Symvivo received from the Government of Canada…
Read More
The authors show that differences in key DNA methylation regulation enzymes are associated with changes in airflow due to inhalation of common allergens, particularly in those with airway hyperresponsiveness. This suggests that fundamental regulators of epigenetics can have more clear functional impact in the context of a strong stimulus in a susceptible host.
Read More